drugset / Trial / NCT06689852

CLINICAL INVESTIGATION FOR THE EVALUATION OF EFFICACY AND SAFETY OF TWO PRODUCTS FOR THE TREATMENT OF ONYCHOMYCOSIS

NCT06689852

RandomizedParallel-groupSingle-blindTreatment

Summary

The efficacy and safety of ENRICHED (X92001591) will be evaluated in a multicentric, randomized, evaluator blinded clinical investigation in 88 patients.

Timeline

Start
2024-10-30
Primary completion
2025-07-04
Completion
2026-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Amorolfine Small molecule 5 %

Indications